Millionaire who wants to live forever stops taking longevity drug over concerns it sped up aging
Bryan Johnson quits rapamycin due to unexpected aging effects, impacting his longevity quest.

Bryan Johnson, a millionaire dedicated to extending his life, stopped using the drug rapamycin after discovering it was accelerating his aging instead of slowing it. Despite promising results in pre-clinical trials, his experience and a recent study led him to abandon the drug, which caused side effects like skin infections.
Johnson initially believed rapamycin, which inhibits the mTOR pathway linked to aging, would aid his longevity efforts but found it had adverse health impacts. These included increased glucose levels and resting heart rate, forcing his team to conclude that the risks overshadowed the benefits.
A Netflix documentary highlighted Johnson's aggressive rapamycin regimen, taken as part of an extensive $2 million annual health protocol. However, the adverse effects and new research findings ultimately led Johnson to discontinue the drug amidst warnings from medical experts about its use for anti-aging.